Skip to main content
. Author manuscript; available in PMC: 2012 Jul 27.
Published in final edited form as: Cancer Cell. 2011 Sep 13;20(3):289–299. doi: 10.1016/j.ccr.2011.08.007

Table 1.

Plasma Proteins with Significantly Elevated Levels in Tumor-Bearing Mice from the Lung Adenocarcinoma Models

Gene Lung Mouse Models
Cell Lines
EGFR Kras Urethane SCLC Total Cell Extract Cell Surface Media
Sftpb 4.83 3.41 1.99 0 1 2

Morc3 * 10 10 0 0 0

Fgfr2 9.8 * 2 1 0

Adam10 7.85 1.5 3 12 11

Man2b2 4.22 1.46 1 0 7

Tfpi2 10 * 5 5 8

Son * 10 1 1 6

Eif2ak3 * 9.03 1 0 0

Hamp2 * 3.07 NA NA NA

Ncan * 1.45 2 1 0

Sftpd 10 10 2 1 3

Mocs1 1.71 1.3 0 0 1

Nup188 * 10 0 1 1

Igsf4a 3.55 1.48 1.55 3.32 0 0 0

Ppbp 1.63 1.7 5.12 1.39 0 0 0

Prtg 10 10 10 0 0 0

Numbers for each mouse model indicate the case:control ratio based on the identification of peptides containing cysteine residues labeled with heavy and light acrylamide isotopes. Dashes (—) indicate that the quantitative ratio was not calculated. Asterisks (*) indicate proteins that were only identified in plasma from tumor-bearing mice. Thirteen proteins were significantly elevated (case:control ratio > 1.25; p < 0.05, t test) in mice bearing lung adenocarcinoma tumors or only identified in tumor bearing mice from at least two of the three lung adenocarcinoma models, but not in any other mouse models. Three proteins (Igsf4a, Ppbp, and Prtg) were increased in mice bearing adenocarcinomas and SCLC tumors but not in the other models. The numbers in the columns for cell lines indicate the number of cell lines in which a protein was identified in any of the whole cell extract, the cell surface, or the conditioned media. The entire dataset is available in Table S4 and Table S5.